133 related articles for article (PubMed ID: 38059272)
1. Evaluation of
Alcorn KN; Oberhauser IA; Politeski MD; Eckroat TJ
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2286935. PubMed ID: 38059272
[TBL] [Abstract][Full Text] [Related]
2. Selective butyrylcholinesterase inhibition by isatin dimers and 3-indolyl-3-hydroxy-2-oxindole dimers.
Reiland KM; Eckroat TJ
Bioorg Med Chem Lett; 2022 Dec; 77():129037. PubMed ID: 36307033
[TBL] [Abstract][Full Text] [Related]
3. Exploring indole-based-thiadiazole derivatives as potent acetylcholinesterase and butyrylcholinesterase enzyme inhibitors.
Taha M; Rahim F; Uddin N; Khan IU; Iqbal N; Anouar EH; Salahuddin M; Farooq RK; Gollapalli M; Khan KM; Zafar A
Int J Biol Macromol; 2021 Oct; 188():1025-1036. PubMed ID: 34390751
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
[TBL] [Abstract][Full Text] [Related]
5. Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease.
Purgatorio R; de Candia M; Catto M; Carrieri A; Pisani L; De Palma A; Toma M; Ivanova OA; Voskressensky LG; Altomare CD
Eur J Med Chem; 2019 Sep; 177():414-424. PubMed ID: 31158754
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of isatin Mannich bases on carbonic anhydrases, acetylcholinesterase, and butyrylcholinesterase.
Ozgun DO; Yamali C; Gul HI; Taslimi P; Gulcin I; Yanik T; Supuran CT
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1498-501. PubMed ID: 26928426
[TBL] [Abstract][Full Text] [Related]
7. In-vitro and in-silico studies of annelated 1,4,7,8-tetrahydroazocine ester derivatives as nanomolar selective inhibitors of human butyrylcholinesterase.
de Candia M; Titov AA; Viayna A; Kulikova LN; Purgatorio R; Piergiovanni B; Niso M; Catto M; Voskressensky LG; Luque FJ; Altomare CD
Chem Biol Interact; 2023 Dec; 386():110741. PubMed ID: 37839515
[TBL] [Abstract][Full Text] [Related]
8. Identification of Compounds for Butyrylcholinesterase Inhibition.
Li S; Li AJ; Travers J; Xu T; Sakamuru S; Klumpp-Thomas C; Huang R; Xia M
SLAS Discov; 2021 Dec; 26(10):1355-1364. PubMed ID: 34269114
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
[TBL] [Abstract][Full Text] [Related]
10. Identification of Potent and Selective Acetylcholinesterase/Butyrylcholinesterase Inhibitors by Virtual Screening.
Xu T; Li S; Li AJ; Zhao J; Sakamuru S; Huang W; Xia M; Huang R
J Chem Inf Model; 2023 Apr; 63(8):2321-2330. PubMed ID: 37011147
[TBL] [Abstract][Full Text] [Related]
11. Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
Vafadarnejad F; Karimpour-Razkenari E; Sameem B; Saeedi M; Firuzi O; Edraki N; Mahdavi M; Akbarzadeh T
Bioorg Chem; 2019 Nov; 92():103192. PubMed ID: 31446239
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
Makhaeva GF; Boltneva NP; Lushchekina SV; Serebryakova OG; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Bachurin SO; Richardson RJ
Bioorg Med Chem; 2016 Mar; 24(5):1050-62. PubMed ID: 26827140
[TBL] [Abstract][Full Text] [Related]
13. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
[TBL] [Abstract][Full Text] [Related]
14. Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insults.
Samarelli F; Purgatorio R; Lopopolo G; Deruvo C; Catto M; Andresini M; Carrieri A; Nicolotti O; De Palma A; Miniero DV; de Candia M; Altomare CD
Eur J Med Chem; 2024 Apr; 270():116353. PubMed ID: 38579622
[TBL] [Abstract][Full Text] [Related]
15. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
[TBL] [Abstract][Full Text] [Related]
16. Triterpene-Based Carboxamides Act as Good Inhibitors of Butyrylcholinesterase.
Loesche A; Kahnt M; Serbian I; Brandt W; Csuk R
Molecules; 2019 Mar; 24(5):. PubMed ID: 30866589
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer's Diseases.
Guo Y; Yang H; Huang Z; Tian S; Li Q; Du C; Chen T; Liu Y; Sun H; Liu Z
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979317
[TBL] [Abstract][Full Text] [Related]
18. Bioactive sulfonyl hydrazones with alkyl derivative: Characterization, ADME properties, molecular docking studies and investigation of inhibition on choline esterase enzymes for the diagnosis of Alzheimer's disease.
Bilen E; Özdemir Özmen Ü; Çete S; Alyar S; Yaşar A
Chem Biol Interact; 2022 Jun; 360():109956. PubMed ID: 35452634
[TBL] [Abstract][Full Text] [Related]
19. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
[TBL] [Abstract][Full Text] [Related]
20. Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations.
Vitorović-Todorović MD; Koukoulitsa C; Juranić IO; Mandić LM; Drakulić BJ
Eur J Med Chem; 2014 Jun; 81():158-75. PubMed ID: 24836068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
